Showing results (1-10 of 1,026) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|December 5, 2021
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trialZelalem Temesgen, Charles D Burger, Jason Baker, et al.
The Lancet. Respiratory Medicine|November 28, 2021
Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumoniaJean-Louis Vincent, Marcel Levi, Beverley J Hunt
The Lancet. Respiratory Medicine|November 5, 2021
Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysisDaniel H Higbee, Raquel Granell, George Davey Smith, et al.
The Lancet. Respiratory Medicine|December 3, 2021
Risk of COVID-19 hospital admission among children aged 5-17 years with asthma in Scotland: a national incident cohort studyTing Shi, Jiafeng Pan, Srinivasa Vittal Katikireddi, et al.
The Lancet. Respiratory Medicine|November 21, 2018
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trialMichael A Matthay, Carolyn S Calfee, Hanjing Zhuo, et al.
The Lancet. Respiratory Medicine|April 6, 2019
Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation studyGanesh Raghu, Kevin R Flaherty, David J Lederer, et al.
The Lancet. Respiratory Medicine|March 17, 2019
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort studyDirkje S Postma, Chris Brightling, Simonetta Baldi, et al.
The Lancet. Respiratory Medicine|March 17, 2019
Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 studyNatasha B Leighl, Matthew D Hellmann, Rina Hui, et al.
The Lancet. Respiratory Medicine|October 3, 2019
Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studiesGerard J Criner, Bartolome R Celli, Dave Singh, et al.
The Lancet. Respiratory Medicine|August 11, 2019
Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trialJean-Michel Constantin, Matthieu Jabaudon, Jean-Yves Lefrant, et al.
Pageof 103